Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hex… Grant US-11116721-B2 United States of America 14 Sep 2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist Grant US-11090294-B2 United States of America 17 Aug 2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist Grant EP-2506844-B1 European Patent Office 20 Dec 2017